The Golden Egg competition awards the three most compelling start-up ideas and offers them a network and advice from industry people. Together with our partner gMendel, we reached the final three with our diagnostic test solution based on artificial intelligence.
gMendel is a Danish start-up founded in 2020 and aiming to transform the diagnosis of genetic disorders for better disease management. Their vision is to bring genome diagnostics into daily clinical practice of rare diseases, ultimately reaching a diagnosis faster. gMendel has developed a breakthrough, first-tier diagnostic test. The test combines the best sequencing and AI technology to deliver accurate and clinically relevant diagnostics in a timely and cost-effective manner. Netcetera is supporting gMendel to establish models and patterns based on the data collections.
We are happy that our contribution is helping people with rare diseases and can have a global positive impact.
Our AI and machine learning offer: